279 results on '"Grisoli, Marina"'
Search Results
2. Tracking longitudinal thalamic volume changes during early stages of SCA1 and SCA2
3. Longitudinal neurofunctional changes in medication overuse headache patients after mindfulness practice in a randomized controlled trial (the MIND-CM study)
4. Intraoperative Comparison Between Strain Elastography and Preoperative Magnetic Resonance Imaging Features in High-Grade Gliomas Using Fusion Imaging: A Pilot Study
5. The cognitive phenotypes of Creutzfeldt-Jakob disease: comparison with secondary metabolic encephalopathy
6. Spinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers
7. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study
8. A surgery-informed precision approach to determining brain targets for real-time fMRI neurofeedback modulation in chronic pain
9. New MAPT variant in a FTD patient with Alzheimer’s disease phenotype at onset
10. The Role of Amide Proton Transfer (APT)-Weighted Imaging in Glioma: Assessment of Tumor Grading, Molecular Profile and Survival in Different Tumor Components.
11. Bilateral Simultaneous Magnetic Resonance–Guided Focused Ultrasound Pallidotomy for Life‐Threatening Status Dystonicus.
12. Cortical network dysfunction revealed by magnetoencephalography in carriers of spinocerebellar ataxia 1 or 2 mutation
13. Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers
14. Focused ultrasound therapy in movement disorders: management roadmap toward optimal pathway organization
15. Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study
16. Correction to: The cognitive phenotypes of Creutzfeldt‑Jakob disease: comparison with secondary metabolic encephalopathy
17. Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort
18. Resting‐state fMRI functional connectome of C9orf72 mutation status
19. Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study.
20. Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment inGBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
21. Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease
22. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study
23. Pain related to MRgFUS: a merely minor transient adverse event?
24. Aceruloplasminemia: Unique Clinical and MRI Findings in a Patient with a Novel Frameshift Mutation.
25. ANO10 mutational screening in recessive ataxia: genetic findings and refinement of the clinical phenotype
26. The optimal targeting for focused ultrasound thalamotomy differs between dystonic and essential tremor. A 12‐month prospective pilot study
27. White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort
28. Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene
29. A discriminative event-based model for subtype diagnosis of sporadic Creutzfeldt-Jakob disease using brain MRI
30. Letter to the editor: A case of functional isolated tongue tremor-like dyskinesia after COVID-19 vaccine
31. Complex Ataxia‐Dementia Phenotype in Patients with Digenic TBP/STUB1 Spinocerebellar Ataxia
32. A discriminative event‐based model for subtype diagnosis of sporadic Creutzfeldt‐Jakob disease using brain MRI
33. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
34. Mathematical models for the diffusion magnetic resonance signal abnormality in patients with prion diseases
35. Role of CT and MRI in Diagnosis and Research
36. Letter to the editor: A case of functional isolated tongue tremor–like dyskinesia after COVID‐19 vaccine
37. D14 Plasma levels of 24S-hydroxycholesterol are reduced in Huntington disease subjects: preliminary results of a 2-year longitudinal study
38. Magnetic Resonance–Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early‐Stage Tremor‐Dominant Parkinson's Disease: A Pilot Study
39. Comparison of arterial spin labeling registration strategies in the multi‐center GENetic frontotemporal dementia initiative (GENFI)
40. Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA‐binding protein 43 inclusions) in missense progranulin mutation Cys139Arg
41. Degenerative Diseases
42. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study
43. Decision-making under risk: A graph-based network analysis using functional MRI
44. Substantia nigra in Parkinson’s disease: a multimodal MRI comparison between early and advanced stages of the disease
45. Fotemustine in recurrent high‑grade glioma: MRI neuro‑radiological findings.
46. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6
47. Pain related to MRgFUS: a merely minor transient adverse event?
48. Neural Signatures of Economic Parameters During Decision-Making: A Functional MRI (fMRI), Electroencephalography (EEG) and Autonomic Monitoring Study
49. Spinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers
50. Biexponential and diffusional kurtosis imaging, and generalised diffusion-tensor imaging (GDTI) with rank-4 tensors: a study in a group of healthy subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.